Contrast performance best with zero spherical aberrations

Article

By using adaptive optics and physiological eye models, Pablo Artal and colleagues from Universidad de Murcia, Spain have determined that contrast performance peaks when spherical aberration is completely corrected.

By using adaptive optics and physiological eye models, Pablo Artal and colleagues from Universidad de Murcia, Spain have determined that contrast performance peaks when spherical aberration is completely corrected.

An adaptive-optics based vision simulator that allowed for simultaneous manipulation of ocular wavefront aberration and measurement of visual performance was created. The simulator consisted of a wavefront sensor, an adaptive optics mirror and a visual testing path. Subjective measurements of contrast sensitivity in five subjects with different levels of naturally occurring spherical aberration, at 15 c/deg with a 4.8 mm pupil, were performed.

Contrast sensitivity was measured for spherical aberration values of -0.09, 0.0, 0.09 and 0.182 µm with the other naturally occurring aberrations of the eye present and corrected and with defocus varying from +0.5 to -0.5 D. The same levels of spherical aberration were compared in physiological eye models to establish tolerances to tilt and decentration and to verify through-focus performance.

Each subject experienced peak contrast sensitivity performance with varying levels of spherical aberration when their natural aberrations were present, however, the average contrast performance peaked with 0 µm of spherical aberration.

The researchers concluded that contrast performance is at its best when spherical aberration is completely corrected.

Recent Videos
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.